Third COVID-19 vaccine dose associated with local and systemic reactions in US observational report

An observational report from the United States described local and systemic reactions in individuals receiving a third dose of COVID-19 vaccine. The report did not specify the vaccine platform, sample size, or follow-up duration. Reactions were reported, but the frequency, severity, or specific types of reactions were not quantified. No comparator data on reactions following a second dose were provided, and no information on serious adverse events, discontinuations, or tolerability was reported. Key limitations include the lack of comparative data, unknown sample size, and absence of quantitative results. The report's practice relevance is limited; it confirms that reactions can occur after a third dose but provides no data to inform comparative risk assessment or patient counseling on expected reaction profiles.